Mitchell Norfleet, PA
Physician Assistant · Gretna, NENPI 1225040900
Payments from drug & device makers
Across 74 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$251
- Novo Nordisk$164
- Amgen$133
- Aimmune Therapeutics, Inc.$98
- Itamar Medical Inc$96
- Pfizer$89
- plus $635 from 22 others
What the payments were for
- Food & beverage$1,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $251 |
| Novo Nordisk | 9 | $164 |
| Amgen | 9 | $133 |
| Aimmune Therapeutics, Inc. | 1 | $98 |
| Itamar Medical Inc | 1 | $96 |
| Pfizer | 5 | $89 |
| Inspire Medical Systems, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 5 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| AstraZeneca | 3 | $43 |
| Boehringer Ingelheim | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
| Heartflow, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Bausch Health US, LLC | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Organon | 1 | $21 |
| Abbott | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| GSK | 1 | $16 |
| Merck | 1 | $15 |
| Exact Sciences | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,465 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 24 | $604 |
| Fluticasone Propionate | 15 | $543 |
| Atorvastatin Calcium | 17 | $366 |
| Levothyroxine Sodium | 15 | $210 |
| Rosuvastatin Calcium | 11 | $140 |
| Lisinopril | 13 | $99 |
| Amlodipine Besylate | 12 | $91 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Gretna
- Lynn KocianGretna$12K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.